Company / Current Liabilities per Share
AYTU BIOPHARMA, INC Current Liabilities per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$10.56
FY2025
5-year range
$2.34 / $35.78
FY2021-FY2025
Trend
-6.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.19 in FY2015 to $82.31 in FY2018.
Based on SEC 10-K filings.
10.56 in FY2025 with a 10-year CAGR of +49.7%.
Improved from $35.78 to $10.56 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +65.1%
- 5-Year CAGR
- +45.1%
- 10-Year CAGR
- +49.7%
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 6.4% year-over-year.
- Peak current liabilities per share was recorded in FY2018.
- Lowest current liabilities per share in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.56 | -6.4% |
| FY2024 | $11.28 | -68.5% |
| FY2023 | $35.78 | +1426.3% |
| FY2022 | $2.34 | -73.0% |
| FY2021 | $8.70 | +430.3% |
| FY2020 | $1.64 | -98.0% |
| FY2018 | $82.31 | +326.5% |
| FY2017 | $19.30 | +126.9% |
| FY2016 | $8.50 | +4447.1% |
| FY2015 | $0.19 | +653.5% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026